Aptus Pharma Limited (BOM:544529)
India flag India · Delayed Price · Currency is INR
285.30
+13.55 (4.99%)
At close: Mar 9, 2026

Aptus Pharma Company Description

Aptus Pharma Limited engages in the marketing and distribution of finished pharmaceutical formulations.

The company operates through four divisions: Aptus Pharma, Pioneer division which includes marketing of acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs; Aptus CD Care, Cardiac Diabetic division which includes marketing of chronic therapies, including anti-hypertensive, anti-diabetic, and lipid-lowering; Aptus Wellcare offers wellness and nutraceutical products, over-the-counter (OTC) formulations, and personal care products; and Aptus Global, export division engages in exploring and developing opportunities in overseas markets, semi-regulated and emerging countries.

It also offers anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products.

Its products are available in balms, capsules, drops, gels, injections, lotions, ointments, powders, sachets, softgels, solutions, suspensions, syrups, tablets, and vials.

It distributes the products through clearing and forwarding agents. Aptus Pharma Limited was incorporated in 2010 and is headquartered in Rajkot, India.

Aptus Pharma Limited
Country India
Founded 2010
Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Employees 70
CEO Ghanshyam Pansuriya

Contact Details

Address:
SHREE Building 1st Floor
Rajkot, Gujarat 360005
India
Phone 91 76 0042 7827
Website aptus-pharma.com

Stock Details

Ticker Symbol 544529
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 5122

Key Executives

Name Position
Ghanshyam Pansuriya Chief Executive Officer
Kapilbhai Chandarana Chief Financial Officer